The Patent Finder

Jazz Pharmaceuticals Therapeutics, Inc.

28 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Celator Pharmaceuticals, Inc. (to 2025)

5
Ending by 2030
Jan 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 5, 2027
    The maintenance fee for Assays and Methods for Selecting a Treatment Regimen for a Subject with Leukemia (US 11,746,386) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
  • 1 fee due Apr 17, 2027
    The maintenance fee for Inhibiting Ataxia Telangiectasia and RAD3-RELATED Protein (ATR) (US 11,787,781) comes due Apr 17, 2027. Unpaid by Oct 18, 2027, it lapses early.
  • 1 fee due Jun 17, 2027
    The maintenance fee for Remote Loading of Sparingly Water-Soluble Drugs into Liposomes (US 10,507,182) comes due Jun 17, 2027. Unpaid by Dec 17, 2027, it lapses early.
  • 1 fee due Aug 25, 2027
    The maintenance fee for Inhibiting Ataxia Telangiectasia and RAD3-RELATED Protein (ATR) (US 10,570,119) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
  • 1 fee due Sep 1, 2027
    The maintenance fee for Compositions for Delivery of Drug Combinations (US 9,271,931) comes due Sep 1, 2027. Unpaid by Mar 1, 2028, it lapses early.
  • 1 fee due Nov 14, 2027
    The maintenance fee for Treatment of Hematological Disorders (US 11,980,636) comes due Nov 14, 2027. Unpaid by May 15, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,850,990Compositions for Delivery of Drug Combinations
In force
 · Medium confidence
In forceMedium confidence
US 8,022,279Liposomal Formulations of Anthracycline Agents and Cytidine Analogs
In force
 · Medium confidence
In forceMedium confidence
US 7,842,676Fixed Ratio Drug Combination Treatments for Solid Tumors
In force
 · High confidence
In forceHigh confidence
US 8,092,828Fixed Drug Ratios for Treatment of Hematopoietic Cancers and Proliferative Disorders
In force
 · High confidence
In forceHigh confidence
US 8,044,052Biaryl Ether Urea Compounds
In force
 · High confidence
In forceHigh confidence
US 9,271,931Compositions for Delivery of Drug Combinations
In force
 · Medium confidence
In forceMedium confidence
US 10,028,912Method of Lyophilizing Liposomes
In force
 · High confidence
In forceHigh confidence
US 10,166,184Method of Lyophilizing Liposomes
In force
 · High confidence
In forceHigh confidence
US 10,835,492Method of Lyophilizing Liposomes
In force
 · High confidence
In forceHigh confidence
US 9,737,485Remote Loading of Sparingly Water-Soluble Drugs into Liposomes
In force
 · Medium confidence
In forceMedium confidence
10 of 28 patents shown.
Pro members see all 28.
Pro members: see all 28 patents
Also on record, not counted in the 28: 5 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited